Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01099345 · ClinicalTrials.gov registry record
A Pilot Trial in a Sleep Laboratory Setting to Observe Night Time Bladder Function of Subjects With Overactive Bladder (OAB)
A clinical trial, sponsored by Astellas Pharma.
- Terminated
- Registry status
- 15
- Enrollment target
NCT01099345: Clinical Trial study, sponsored by Astellas Pharma.
NCT01099345 is a clinical trial that was terminated before completion, run by Astellas Pharma. The registered enrollment target is 15 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01099345 was terminated before completion, sponsored by Astellas Pharma.
- TERMINATED
- Registry status
- 15 participants
- Enrollment target
Study Summary
This is an observational, pilot, non-treatment study to evaluate and develop clinical variables for distinguishing female OAB subjects that have detrusor overactivity positive (DO+) nocturia from female OAB subjects that have detrusor overactivity negative (DO-) nocturia utilizing a sleep laboratory setting.
Interventions
- PROCEDURE cystometry (CMG)
- PROCEDURE polysomnography (PSG)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2010-07 |
| Est. Completion | 2012-05 |
Why NCT01099345 stopped before completion
NCT01099345 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 15 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which cystometry (CMG) is the first listed.
NCT01099345 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01099345 about?
NCT01099345 is a clinical study titled "A Pilot Trial in a Sleep Laboratory Setting to Observe Night Time Bladder Function of Subjects With Overactive Bladder (OAB)". This is an observational, pilot, non-treatment study to evaluate and develop clinical variables for distinguishing female OAB subjects that have detrusor overactivity positive (DO+) nocturia from female OAB subjects that have detrusor overactivity negative (DO-) nocturia utilizing a sleep laboratory...
What is the current status of trial NCT01099345?
This trial is currently terminated. The enrollment target is 15 participants. The study started on 2010-07. Estimated completion is 2012-05.
What interventions are being tested in trial NCT01099345?
The interventions under investigation include: cystometry (CMG) (PROCEDURE), polysomnography (PSG) (PROCEDURE).
Who is sponsoring clinical trial NCT01099345?
This trial is sponsored by Astellas Pharma, which has 165 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01889381 · 15 participants · Phase 2
Human Craniomaxillofacial Allotransplantation
- NCT02530073 · 15 participants · NA
Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH
- NCT02535936 · 15 participants · NA
Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy
- NCT02918474 · 15 participants · NA
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia